Kyntra Bio (KYNB) Work In Process (2018 - 2024)
Kyntra Bio (KYNB) posted Work In Process of $3.2 million for Q4 2024, down 82.25% sequentially from $17.8 million in Q3 2024, and down 80.75% YoY from $16.4 million in Q1 2024.
Kyntra Bio (KYNB) Work In Process (2018 - 2024) Analysis & Trends
Kyntra Bio has reported Work In Process for 7 years, with the latest figure at $3.2 million in Q4 2024.
- Quarterly Work In Process fell 80.75% year-over-year to $3.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.2 million (down 80.75% YoY) and the FY2024 annual result came in at $3.2 million, down 80.75% from the prior year.
- Work In Process eased to $3.2 million in Q4 2024 per KYNB's latest filing, from $17.8 million in the prior quarter.
- Over five years, Work In Process peaked at $37.3 million in Q1 2023 and troughed at $2.9 million in Q1 2020.
- A 5-year average of $20.6 million and a median of $20.0 million in 2024 frame the typical range for Work In Process.
- The sharpest annual moves came in 2021 and 2024: Work In Process surged 307.37% in 2021, then tumbled 80.75% in 2024.
- Over 5 years, Work In Process stood at $8.1 million in 2020, then soared by 164.96% to $21.5 million in 2021, then jumped by 67.46% to $36.0 million in 2022, then slumped by 54.49% to $16.4 million in 2023, then sank by 80.75% to $3.2 million in 2024.
- According to Business Quant data, Work In Process over the past three periods registered $3.2 million, $17.8 million, and $19.5 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Kyntra Bio | 29.83 Mn | 29.83 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.16 Mn |
| Sep 30, 2024 | 17.78 Mn |
| Jun 30, 2024 | 19.49 Mn |
| Mar 31, 2024 | 20.60 Mn |
| Dec 31, 2023 | 16.39 Mn |
| Sep 30, 2023 | 34.91 Mn |
| Jun 30, 2023 | 35.35 Mn |
| Mar 31, 2023 | 37.27 Mn |
| Dec 31, 2022 | 36.00 Mn |
| Sep 30, 2022 | 35.21 Mn |
| Jun 30, 2022 | 34.49 Mn |
| Mar 31, 2022 | 33.84 Mn |
| Dec 31, 2021 | 21.50 Mn |
| Sep 30, 2021 | 20.66 Mn |
| Jun 30, 2021 | 15.54 Mn |
| Mar 31, 2021 | 9.66 Mn |
| Dec 31, 2020 | 8.11 Mn |
| Sep 30, 2020 | 5.62 Mn |
| Jun 30, 2020 | 3.82 Mn |
| Mar 31, 2020 | 2.95 Mn |